Disruption of this balance, as observed in obesity and T2D, favors YY1-mediated inflammation and metabolic dysfunction, while RKIP downregulation eliminates critical inhibitory checkpoints. This evidence concerns the gene YY1 and type 2 diabetes mellitus.